Targeted Hope
News & Events

January 2011
 News Coverage & Suggested Videos
Find us on Facebook  Follow us on Twitter Find us on Facebook   

CBS 60 Minutes: Emerging Technology: Hope for Transplant Patients & Amputees

In this Issue
Upcoming Events
Cures for Quality of Life
Targeted Hope: Cord Blood
More Targeted Hope for Blindness
Targeted Hope for Alzheimer's
Texans for Stem Cell Research 
2nd Annual Educational Symposium
AT&T Executive Education And Conference Center at UT Austin
September 30th, 2011
Austin, Texas

 Cures for Quality of Life

"The enemy is the disease or injury that is destroying our friends and families' quality of life, and that is what we must defeat. The mission is to bring the benefits of pluripotential and progenitor cell therapy to regenerative medicine.  That is what we are doing.."   

Dr. Alan Trounson, President 
                                     California Institute for Regenerative Medicine

Targeted Hope
Cure-Focused Research

Scientists are convinced that stem cells can be used to treat injured hearts, spinal cords, brain and treat diabetes, Parkinson's, Alzheimer's, MS and many other conditions.  In the Targeted Hope section of our newsletter, we will highlight diseases specific treatments for which stem cell research is showing great promise. This issue will include information on cord blood banking and updates on developing cell-based therapies for Alzheimer's, blindness, and spinal cord injury.Watch for Targeted Hope to highlight Heart & Vascular Diseases next month.
Cord Blood Stem Cells Gaining Momentum

Stem Cell research has been called one of the most important medical breakthroughs in decades. In 1989, cord blood banking was created for the purpose of collecting and storing stem cells from this invaluable resource. Cord blood stem cells are currently used in disease treatment to fight over 70 diseases including many forms of malignancies such as leukemia, autoimmune diseases, lupus, and inheritable diseases such as sickle cell anemia. Stem Cell research is exploring new applications for treatment every day.  This research may prove effective in the future treatment of many common diseases and injuries that plague today's society, including spinal cord injury, stroke, Parkinson's disease, Alzheimer's disease, heart disease, diabetes, bone regeneration, hearing and HIV.   As stem cell science advances, the importance of saving these cells increases exponentially. (See Attached to Read More)

Facts about Umbilical Cord Blood Transplantation    Cord Blood Transplant Centers    Texas Cord Blood Bank (TCBB)

Learn if You Can Donate Cord Blood     Texas Public Cord Blood Banks in (NMDP) Network  

New Hope for 
National Cord Blood Inventory 

StemCyte was recently awarded two grants for advance therapies using Umbilical Cord Blood Stem Cells (UCB stem cells) for the potential treatment of chronic spinal cord injury and chronic stroke. StemCyte is actively involved in the development of new umbilical cord blood-based cell therapies and has supplied over 1,300 cord blood products for over 40 life-threatening diseases to over 200 leading worldwide transplant centers. They are the only for-profit company contracted by the US Department of HHS to establish a public National Cord Blood Inventory for unrelated transplant units. These awards demonstrate the commitment to continued development of new therapies to treat chronic condition, address unmet medical needs, reduce health care costs, and advance the goal of cures. . (...full release

Second Green Light for Blindness...

"After a decade of intense controversy, the field is finally ready to start proving itself and to actually start helping patients suffering from a range of horrific diseases"  
                                    -- Bob Lanza, Chief Scientist at Advanced Cell Technology

A US biotech company, Advanced Cell Technology (ACT), was cleared by the government to start its second trial using embryonic stem cells to treat blindness, this time in older people. ACT is the first company to receive FDA clearance for two(2) translational hESC trials making them a true leader in the field of regenerative medicine. This is widely recognized as a major step forward within the stem cell sector and potentially for modern healthcare techniques.  (Read More)

US stem cell research breaks new ground in 2010 
Developing Therapies for Alzheimer's

Stem cell research is bringing scientists closer to being able to test drugs for Alzheimer's; a disease that afflicts more than five million Americans.  There is no cure for the disease, but we should not let impatience with the pace of progress divert us from pursuing the opportunities that hold future promise.  It can take many years to go from the blackboard to the laboratory bench and then onto the clinic.  For example, bone marrow derived stem cells, which are now a common treatment for leukemia, took quite awhile to turn that into a useable therapy.  We just have to remember that it takes time.  (Read More)

Save the Dates...
News &
Upcoming Events


Happy New Year Friends. 


We are proud to announce that we will host our 2nd Annual Stem Cell Educational Symposium, September 30th in Austin.  We have already received commitments from our internationally recognized stem cell scientists and doctors currently conducting promising stem cell clinical trials in Texas including:  Dr. James Willerson, Texas Heart Institute, Dr. Darwin Prockop, Director of Texas A&M Regenerative Medicine Institute, Dr. Sean Savitz, University of Texas Health Science Center Houston, and Dr. William Decker, University of Texas, M.D. Anderson Cancer Center . 


In addition to these amazing Texas-based leaders, we are honored to have a commitment from Dr. Wise Young, Rutgers University Director of the WM Keck Center for Collaborative Neuroscience and Denis Rodgerson, Ph.D, Professor Emeritus Pathology and Laboratory Medicine at UCLA. Dr. Young is a well known leader in spinal cord injury research and appeared on "20/20" with Barbara Walters and Christopher Reeve.  His work has also been featured in Life magazine (Read More


Dr. Rodgerson is currently the Director of Stem Cell Science at NeoStem, Inc. a company that specializes in the collection, processing and long term storage of adult stem cells for future therapeutic use. He was the initial founder of NeoStem and has published more than 150 articles in the medical and scientific literature. 


We are also pleased to announce a very special guest this year, Don Reed, arguably one of the leading stem cell advocates in the United States, who will travel to Texas this fall and tell us his story.  Don's son, Roman, was paralyzed playing college football 16 years ago. This devastating accident resulted in Don dedicating his life to helping his son walk again. His drive and dedication was instrumental in California passing Proposition 71, the law, which has raised $3 billion for stem cell research. This proposition was the first of its kind and has inspired other states and advocates following California's lead. Don is truly an inspiration and we look forward to his visit.


We are positioned for another strong year and will release additional details in the coming weeks.




David L. Bales, Chariman
Texans for Stem Cell Research

Becker Science Center's Annual Science Day
Co-organized by Texas-Israel Chamber of Commerce
Wednesday, January 26, 2011, 6:45 - 8 p.m. 
Austin, Texas

Dell Jewish Community Campus/ Becker Science Center at Austin Jewish Academy -Community Hall, Stageside
7300 Hart Lane  Austin, TX 78731
RSVP:  info@texasisrael.org or (214) 576-9692

Cell Society's 1st Annual Clinical Meeting
February 18th-19th, 2011
La Jolla, California 

Demand and interest in adult stem cell therapies is increasing. However, it has been challenging for physicians, patients and policy-makers to retrieve the most current and accurate information available.  Cell Society was created to ensure that the evolving arena of adult stem cell research gets the attention it deserves and to facilitate a network for patients, physicians, policy makers and advocates to find each another and share information. The Cell Society's 1st Annual Clinical faculty includes national and international physicians, as well as several individuals who are well-versed in US policy surrounding stem cell therapy applications. Corporate scientists will also give updates on the research and clinical trials that are happening right now.   If you are interested in this upcoming meeting you may register here.     Cell Society Website

Type1Now Conference 
April 2, 2011
Austin, Texas

The Austin chapter of the Juvenile Diabetes Research Foundation (JDRF) announces the first ever Type1Now Conference-a full day of education and resources on all aspects of living with the condition for all individuals personally affected by type 1. The keynote speaker will be Dr. Steve Ponder, a luminary in the field of diabetes management. Participants will have the rare opportunity to learn from respected professionals in the field as well as a chance to share practical tips and techniques for better management of the chronic disease. (Read More)

9th Annual International Umbilical Cord Blood Transplantation Symposium
Jun 23-25, 2011
San Francisco, California

Premier cord blood transplantation meeting, attracting physicians, researchers, cord blood bankers, laboratory personnel, nurses, patients and administrators from around the globe.   (Read More)

Texans for Stem Cell Research is a 501(c)3 non-profit organization. We continue to advocate for responsible public policy and promote the advancement of safe and effective stem cell research and therapy throughout Texas. We believe educating our citizens will allow Texas to regain its rightful place as a leader in stem cell medical research and treatments.  In order to provide quality education, we rely on your continued support and donations. If you are interested in 2011 sponsorship opportunites, please contact David L. Bales (512) 797-2703.  

Check out @helpattack...
Pledge and Give to Texans for Stem Cell Research 
Each time you Tweet